|
FAQ
Regarding the IMOVAX® Rabies Vaccine Product
Recall
Updated April 15, 2004
FDA and CDC have been notified by Aventis Pasteur of a recent Quality
Assurance test that revealed the presence of non-inactivated Pitman-Moore
virus (the attenuated vaccine strain) in a single product lot. IMOVAX
is an inactivated viral vaccine and should not contain live virus. This
above-mentioned lot was not distributed. As a precautionary measure,
Aventis Pasteur has decided to initiate a voluntary recall of lots which
were produced during the same time period. Recalled lots passed all release
tests, including testing to confirm the absence of live virus, and no
unusual adverse events associated with the recalled vaccine have been
reported.
Please select the category that most closely fits.
|
